Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazunari Tanabe

Showing results (1-10 of 458) with videos related to

Pageof 46
Sort By:
Drugs|July 31, 2003
Calcineurin inhibitors in renal transplantation: what is the best option?Kazunari Tanabe
Transplantation|January 25, 2008
Interinstitutional variation in the measurement of anti-A/B antibodies: the Japanese ABO-Incompatible Transplantation Committee surveyKazunari Tanabe
Transplantation|January 25, 2008
Japanese experience of ABO-incompatible living kidney transplantationKazunari Tanabe
Transplantation|January 25, 2008
Double-filtration plasmapheresisKazunari Tanabe
International Journal of Urology : Official Journal of the Japanese Urological Association|April 21, 2012
Role of lymphadenectomy in the management of urothelial carcinoma of the bladder and the upper urinary tractTsunenori Kondo, Kazunari Tanabe
Hinyokika Kiyo. Acta Urologica Japonica|September 3, 2010
[Marginal donor and high risk recipient in kidney transplantation]Hiroki Shirakawa, Kazunari Tanabe
Nephrology (Carlton, Vic.)|March 19, 2016
Prevention and treatment of atypical haemolytic uremic syndrome after kidney transplantationMasayoshi Okumi, Kazunari Tanabe
Therapeutics and Clinical Risk Management|October 2, 2008
Efficacy of deoxyspergualine for antibody-mediated rejection and proteinuria after kidney transplantationHideki Ishida, Kazunari Tanabe
Clinical Transplantation|December 5, 2013
Desensitization for prevention of chronic antibody-mediated rejection after kidney transplantationKazunari Tanabe, Masashi Inui
International Journal of Clinical Oncology|April 22, 2011
The role of lymph node dissection in the management of urothelial carcinoma of the upper urinary tractTsunenori Kondo, Kazunari Tanabe
Pageof 46

Showing results (1-10 of 458) with videos related to

Sort By:
Pageof 46
Drugs|July 31, 2003
Calcineurin inhibitors in renal transplantation: what is the best option?Kazunari Tanabe
Transplantation|January 25, 2008
Interinstitutional variation in the measurement of anti-A/B antibodies: the Japanese ABO-Incompatible Transplantation Committee surveyKazunari Tanabe
Transplantation|January 25, 2008
Japanese experience of ABO-incompatible living kidney transplantationKazunari Tanabe
Transplantation|January 25, 2008
Double-filtration plasmapheresisKazunari Tanabe
International Journal of Urology : Official Journal of the Japanese Urological Association|April 21, 2012
Role of lymphadenectomy in the management of urothelial carcinoma of the bladder and the upper urinary tractTsunenori Kondo, Kazunari Tanabe
Hinyokika Kiyo. Acta Urologica Japonica|September 3, 2010
[Marginal donor and high risk recipient in kidney transplantation]Hiroki Shirakawa, Kazunari Tanabe
Nephrology (Carlton, Vic.)|March 19, 2016
Prevention and treatment of atypical haemolytic uremic syndrome after kidney transplantationMasayoshi Okumi, Kazunari Tanabe
Therapeutics and Clinical Risk Management|October 2, 2008
Efficacy of deoxyspergualine for antibody-mediated rejection and proteinuria after kidney transplantationHideki Ishida, Kazunari Tanabe
Clinical Transplantation|December 5, 2013
Desensitization for prevention of chronic antibody-mediated rejection after kidney transplantationKazunari Tanabe, Masashi Inui
International Journal of Clinical Oncology|April 22, 2011
The role of lymph node dissection in the management of urothelial carcinoma of the upper urinary tractTsunenori Kondo, Kazunari Tanabe
Pageof 46